Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol. 2009 Jul 01; 27(19):3133-40.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Benzenesulfonates
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Recurrence, Local
Niacinamide
Phenylurea Compounds
Pyridines
Sarcoma
Young Adult
authors with profiles
Andrew S Kraft